Skip to main content

Table 1 General characteristics of study participants

From: The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

  Placebo group (n = 30) Synbiotic group (n = 30) pa
Age (y) 25.9 ± 5.2 25.7 ± 5.5 0.90
Height (cm) 163.3 ± 6.6 161.4 ± 5.8 0.25
Weight at study baseline (kg) 72.4 ± 14.1 71.4 ± 11.6 0.79
Weight at end-of-trial (kg) 71.9 ± 14.4 71.2 ± 11.4 0.83
Weight change (kg) −0.4 ± 1.0 − 0.3 ± 1.2 0.53
BMI at study baseline (kg/m2) 27.2 ± 5.3 27.4 ± 4.0 0.84
BMI at end-of-trial (kg/m2) 27.0 ± 5.4 27.3 ± 3.9 0.80
BMI change (kg/m2) −0.2 ± 0.3 − 0.1 ± 0.4 0.49
MET-h/day at study baseline 27.5 ± 2.0 27.7 ± 2.1 0.60
MET-h/day at end-of-trial 27.6 ± 2.2 27.8 ± 2.3 0.69
MET-h/day change 0.1 ± 0.6 0.04 ± 1.0 0.83
  1. Data are means± SDs
  2. aObtained from independent t test. METs, metabolic equivalents